Literature DB >> 31279993

Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree.

Stephen S Chen1, Nick A Zaborek2, Amanda R Doubleday2, Sarah C Schaefer2, Kristin L Long2, Susan C Pitt2, Rebecca S Sippel2, David F Schneider2.   

Abstract

BACKGROUND: After thyroidectomy, patients require Levothyroxine (LT4). It may take years of dose adjustments to achieve euthyroidism. During this time, patients encounter undesirable symptoms associated with hypo- or hyper-thyroidism. Currently, providers adjust LT4 dose by clinical estimation, and no algorithm exists. The objective of this study was to build a decision tree that could estimate LT4 dose adjustments and reduce the time to euthyroidism.
METHODS: We performed a retrospective cohort analysis on 320 patients who underwent total or completion thyroidectomy at our institution. All patients required one or more LT4 dose adjustments from their initial postoperative dose before attaining euthyroidism. Using the Classification and Regression Tree algorithm, we built various decision trees from patient characteristics, estimating the dose adjustment to reach euthyroidism.
RESULTS: The most accurate decision tree used thyroid-stimulating hormone values at first dose adjustment (mean absolute error = 13.0 μg). In comparison, the expert provider and naïve system had a mean absolute error of 11.7 μg and 17.2 μg, respectively. In the evaluation dataset, the decision tree correctly predicted the dose adjustment within the smallest LT4 dose increment (12.5 μg) 79 of 106 times (75%, confidence interval = 65%-82%). In comparison, expert provider estimation correctly predicted the dose adjustment 76 of 106 times (72%, confidence interval = 62%-80%).
CONCLUSIONS: A decision tree predicts the correct LT4 dose adjustment with an accuracy exceeding that of a completely naïve system and comparable to that of an expert provider. It can assist providers inexperienced with LT4 dose adjustment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31279993      PMCID: PMC7041547          DOI: 10.1016/j.jss.2019.06.025

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

1.  Quality of life, depressive symptoms and anxiety in hyperthyroid patients.

Authors:  A Suwalska; K Lacka; D Lojko; J K Rybakowski
Journal:  Rocz Akad Med Bialymst       Date:  2005

2.  Levothyroxine dose following thyroidectomy is affected by more than just body weight.

Authors:  Kara Meinke Baehr; Elizabeth Lyden; Kelly Treude; Judi Erickson; Whitney Goldner
Journal:  Laryngoscope       Date:  2012-02-28       Impact factor: 3.325

Review 3.  Levothyroxine absorption in health and disease, and new therapeutic perspectives.

Authors:  G Ianiro; F Mangiola; T A Di Rienzo; S Bibbò; F Franceschi; A V Greco; A Gasbarrini
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

4.  Predicting thyroxine requirements following total thyroidectomy.

Authors:  Dipan Mistry; Stephen Atkin; Helen Atkinson; Sinnappa Gunasekaran; Deborah Sylvester; Alan S Rigby; R James England
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

5.  Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States.

Authors:  Julie Ann Sosa; John W Hanna; Karen A Robinson; Richard B Lanman
Journal:  Surgery       Date:  2013-10-02       Impact factor: 3.982

6.  Using body mass index to predict optimal thyroid dosing after thyroidectomy.

Authors:  Kristin A Ojomo; David F Schneider; Alexandra E Reiher; Ngan Lai; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Am Coll Surg       Date:  2013-01-11       Impact factor: 6.113

7.  Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life-a Brazilian multicentre study.

Authors:  Patrícia dos Santos Vigário; Fernanda Vaisman; Cláudia Medina Coeli; Laura Ward; Hans Graf; Gisah Carvalho; Renan Montenegro Júnior; Mário Vaisman
Journal:  Endocrine       Date:  2013-01-31       Impact factor: 3.633

8.  Association of Surgeon Volume With Outcomes and Cost Savings Following Thyroidectomy: A National Forecast.

Authors:  Zaid Al-Qurayshi; Russell Robins; Adam Hauch; Gregory W Randolph; Emad Kandil
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-01       Impact factor: 6.223

9.  Prospective Intervention of a Novel Levothyroxine Dosing Protocol Based on Body Mass Index after Thyroidectomy.

Authors:  Dawn M Elfenbein; Sarah Schaefer; Cynthia Shumway; Herbert Chen; Rebecca S Sippel; David F Schneider
Journal:  J Am Coll Surg       Date:  2015-10-21       Impact factor: 6.113

10.  The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

Authors:  Frank R Ernst; Peri Barr; Riad Elmor; Walter Sandulli; Lionel Thevathasan; Arnold B Sterman; Jessica Goldenberg; Kevin Vora
Journal:  Clin Drug Investig       Date:  2017-01       Impact factor: 2.859

View more
  7 in total

1.  Optimal Thyroid Hormone Replacement.

Authors:  Jacqueline Jonklaas
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 25.261

Review 2.  Hyperthyroidism.

Authors:  Amanda R Doubleday; Rebecca S Sippel
Journal:  Gland Surg       Date:  2020-02

3.  Radiofrequency ablation and thyroid nodules: updated systematic review.

Authors:  Haris Muhammad; Prasanna Santhanam; Jonathon O Russell
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

4.  Machine learning identifies baseline clinical features that predict early hypothyroidism in patients with Graves' disease after radioiodine therapy.

Authors:  Lian Duan; Han-Yu Zhang; Min Lv; Han Zhang; Yao Chen; Ting Wang; Yan Li; Yan Wu; Junfeng Li; Kefeng Li
Journal:  Endocr Connect       Date:  2022-05-27       Impact factor: 3.221

Review 5.  Levothyroxine Therapy in Thyrodectomized Patients.

Authors:  Paolo Miccoli; Gabriele Materazzi; Leonardo Rossi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

6.  Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models.

Authors:  Yan Zhang; Jaina Razbek; Deyang Li; Lei Yang; Liangliang Bao; Wenjun Xia; Hongkai Mao; Mayisha Daken; Xiaoxu Zhang; Mingqin Cao
Journal:  BMC Public Health       Date:  2022-02-08       Impact factor: 3.295

7.  A machine learning approach to personalized dose adjustment of lamotrigine using noninvasive clinical parameters.

Authors:  Xiuqing Zhu; Wencan Huang; Haoyang Lu; Zhanzhang Wang; Xiaojia Ni; Jinqing Hu; Shuhua Deng; Yaqian Tan; Lu Li; Ming Zhang; Chang Qiu; Yayan Luo; Hongzhen Chen; Shanqing Huang; Tao Xiao; Dewei Shang; Yuguan Wen
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.